Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.

Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.

Zhitong FinanceFeb 20 09:58

Express News | Beijing Strong Biotechnologies, Inc.: Shareholder ZHOU XIAOYAN plans to reduce his Shareholding by 0.11% of the company.

BreakingsFeb 17 19:48

Express News | Beijing Strong Biotechnologies, Inc.: A wholly-owned subsidiary has completed the filing for the first category of medical instruments.

BreakingsJan 6 16:46

Express News | Beijing Strong Biotechnologies, Inc.: obtained the medical instruments registration certificate for the cardiac troponin I assay kit (fluorescent immunochromatography method).

BreakingsJan 2 15:50

Express News | Beijing Strong Biotechnologies, Inc.: The company's executive vice president SHENG DAN has resigned.

BreakingsDec 31, 2024 17:15

Beijing Strong Biotechnologies, Inc. (300406.SZ): China National Pharmaceutical Investment has cumulatively increased its Shareholding by 4.3408 million shares, and the increase has been completed.

On December 24, Gelonghui reported that Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that on December 24, 2024, it received a letter from China Meheco Group, a shareholder holding more than 5% of the shares, regarding the implementation of the Shareholding plan. As of the date of this announcement, the Shareholding plan has been completed, with China Meheco Group increasing its shares by a total of 4,340,800 shares through centralized bidding, accounting for 0.74% of the company's shares with voting rights, with an increase amounting to 62,283,792.00 yuan.

Gelonghui FinanceDec 24, 2024 15:58